Frontier Science & Technology Research Foundation
Frontier Science & Technology Research Foundation is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
IBCSG 67-22 PREcoopERA: A Window-of-Opportunity trial of giredestrant +/- triptorelin vs. anastrozole + triptorelin in premenopausal patients with ER-positive/HER2-negative early breast cancer.
Sponsor ETOP IBCSG Partners Foundation
- Start (EU)
- Latest update
- Estimated end
Operational learnings available2 trial-level findings · Read insights
- The trial randomized 231 patients at 33 centers in six countries between 25 January 2024 and 15 July 2025, exceeding the planned randomization of 220 patients.
- Of 231 randomized patients, 226 initiated window-of-opportunity treatment, 216 had paired biopsies, and 204 met criteria for the primary analysis population.
These findings describe the trial, not the service provider’s performance or responsibility.
POLAR: A phase III open-label, multicenter, randomized trial of adjuvant palbociclib in combination with endocrine therapy versus endocrine therapy alone for patients with hormone receptor positive / HER2-negative resected isolated locoregional recurrence of breast cancer
Sponsor ETOP IBCSG Partners Foundation
- Start (EU)
- Latest update
- Estimated end
A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients with Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg
Sponsor Actelion Pharmaceuticals Ltd.
- Start (EU)
- Latest update
- Estimated end
A multicenter, open-label, randomized study with single-arm extension period to assess the pharmacokinetics, safety and efficacy of macitentan versus standard of care in children with pulmonary arterial hypertension
Sponsor Actelion Pharmaceuticals Ltd.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Frontier Science & Technology Research Foundation?
The 2026-10-09 snapshot links Frontier Science & Technology Research Foundation to 4 distinct CTIS trials. Recorded services include Data management, Statistical analysis, interaction with IDMC. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Frontier Science & Technology Research Foundation?
The most frequently recorded therapeutic areas are Solid Tumor Oncology. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Frontier Science & Technology Research Foundation conducted?
The linked trials record locations in 17 countries, including Spain, Hungary, France, Italy, Austria. These are trial locations, not confirmed office locations or countries where Frontier Science & Technology Research Foundation delivered services.
What can this page tell me about Frontier Science & Technology Research Foundation's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Frontier Science & Technology Research Foundation. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Frontier Science & Technology Research Foundation Inc.